| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $24.4M | +60.1% |
| Cost of Revenue | $2.8M | +110.4% |
| R&D Expense | $48.9M | +49.8% |
| SG&A Expense | $44.5M | +10.9% |
| Operating Income | -$71.9M | -14.8% |
| Interest Expense | $231K | +0.4% |
| Pre-tax Income | -$65.8M | -8.7% |
| Income Tax | $0 | — |
| Net Income | -$65.8M |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $62.9M | +61.2% |
| Short-term Investments | $46.0M | -65.6% |
| Accounts Receivable | $5.5M | +194.7% |
| Inventory | $6.4M | +245.4% |
| Current Assets | $124.6M | -30.8% |
| Total Assets | $132.4M | -28.1% |
| Current Liabilities | $26.4M | +40.1% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$59.7M | -20.2% |
| Capital Expenditures | $4.0M | +794.6% |
| Investing Cash Flow | $83.2M | +162.6% |
| Financing Cash Flow | $326K | -99.6% |
| Free Cash Flow | -$63.6M | -27.1% |
| -8.7% |
| EPS (Basic) | -$2.44 | +9.3% |
| EPS (Diluted) | -$2.44 | +9.3% |
| Total Liabilities |
| $27.2M |
| +5.3% |
| Stockholders' Equity | $105.2M | -33.6% |